H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 10.7% of adults in Wilmington have diagnosed diabetes — 1.3 points below the U.S. 12% figure. Census population 115,451. North Carolina Medicare wound biologics: Palmetto GBA (JM). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Wilmington clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Wilmington storefront.
Chronic Wound Treatment That Works in Wilmington, NC for clinics & physicians. Effective chronic wound tre… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 10.7% of adults in Wilmington have diagnosed diabetes — 1.3 points below the U.S. 12% figure. Census city-proper population is 115,451. If you are adding chronic wound treatment, start with that epidemiology and with Palmetto GBA (JM) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Chronic Wound Treatment That Works notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Wilmington we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 10.7% of adults in Wilmington have diagnosed diabetes — 1.3 points below the U.S. 12% figure.
We are not going to invent a Wilmington warehouse or a five-star local review. What you get is chronic wound treatment from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JM, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 10.7% of adults — 1.3 points below the U.S. 12% figure. Obesity is 31.9%; arthritis is 26%. That is place-level BRFSS modeling, not a clinic census and not a Wilmington trial.
Point-of-care spin, kit handling, and documentation basics. Injection technique, privileging, and ultrasound guidance remain the clinic’s clinical education path in North Carolina.
North Carolina is in CMS MAC JM, administered by Palmetto GBA. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a North Carolina compliance risk.
If you operate in North Carolina and another MAC state, say it on the first call. JM will not port 1:1. We would rather split utilization than watch a sister clinic copy Wilmington tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Wilmington, NC.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Wilmington is JM geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Wilmington — 1.3 points below the U.S. 12% figure. Planning input, not an outcomes claim.
North Carolina Part B wound biologics follow this contractor (siblings: SC, VA, WV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Wilmington. Useful for joint-program math; still needs a diagnosis and privileging.
No Wilmington storefront. Joe Bradley is an active practice owner. chronic wound treatment stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.